Julie A. Vetalice, Author at ORTHOWORLD

Amedica Rebrands as SINTX Technologies

Amedica is changing its corporate name to SINTX Technologies to better reflect its focus on core competence in the science and production of silicon nitride ceramics, following the recent sale of its spine portfolio to CTL Medical.

Oct 31, 2018

Zimmer Biomet Completes First Procedures Using ROSA Knee Robot

ORTHOFLASH Robotics/Tech

Zimmer Biomet completed the first procedures using its ROSA knee robot for total knee replacement.

Oct 31, 2018

Life Spine’s First Clinical Cases with PROLIFT Post Pack Expandable Interbody

ORTHOFLASH Spine

Initial clinical cases have been performed with Life Spine's PROLIFT® Post Pack expandable interbody system.

Oct 30, 2018

CartiHeal Reaches 100th Surgery in Agili-C IDE Study

Orthobiologics ORTHOFLASH

CartiHeal has successfully enrolled and treated the 100th patient in the pivotal IDE study of the Agili-C implant.

Oct 26, 2018

Aurora Spine Granted EU Patent for ZIP Minimally Invasive Spinal Devices

ORTHOFLASH Spine

Aurora Spine was granted an EU Patent covering ZIP® interspinous devices.

Oct 25, 2018

AAOS Launches Shoulder and Elbow Registry

Joint Replacement ORTHOFLASH

The American Academy of Orthopaedic Surgeons launched the Shoulder and Elbow Registry in the U.S.

Oct 25, 2018

Study Results: DJO EMPOWR 3D Knee Reduces Patient Dissatisfaction

Joint Replacement ORTHOFLASH

Results from a clinical study of DJO's EMPOWR 3D Knee indicate that the technology reduces patient dissatisfaction while improving function and activity levels.

Oct 23, 2018

BONESUPPORT Begins Direct U.S. Sales of CERAMENT Bone Void Filler

Orthobiologics ORTHOFLASH

BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF.

Oct 23, 2018

MinInvasive Launches OmniCuff in the US

ORTHOFLASH Sports Medicine

MinInvasive commenced limited U.S. launch of the OmniCuff device for rotator cuff repair.

Oct 23, 2018

Regentis Biomaterials Expands SAGE Trial of GelrinC

Orthobiologics ORTHOFLASH

Regentis Biomaterials expanded the SAGE clinical trial of GelrinC to 11 U.S. sites. The investigational device is in evaluation to regrow knee cartilage.

Oct 23, 2018

Get the ORTHOWORLD Newsletter!

Contact Us